Unipolar depression is the clinical term for major depressive disorder, a condition defined by persistent low mood or loss of interest in daily life without the manic or hypomanic episodes seen in bipolar disorder. It affects roughly 5.7% of adults worldwide, or about 332 million people, making it one of the most common mental health conditions on the planet.
The “unipolar” label exists specifically to distinguish it from bipolar depression. In bipolar disorder, people cycle between depressive episodes and periods of abnormally elevated mood, energy, or irritability (mania or hypomania). In unipolar depression, mood shifts in only one direction: down.
How It’s Diagnosed
A diagnosis requires at least five specific symptoms lasting two weeks or more, and at least one of those symptoms must be either a persistently depressed mood or a noticeable loss of interest or pleasure in activities you used to enjoy. The remaining symptoms include feelings of guilt or worthlessness, fatigue or low energy, trouble concentrating, appetite changes (eating significantly more or less than usual), sleep disturbances (insomnia or oversleeping), physical restlessness or feeling slowed down, and recurring thoughts of death or suicide.
These symptoms also need to cause meaningful impairment in your daily functioning, whether that’s at work, in relationships, or in basic self-care. Feeling sad for a few days after a difficult event doesn’t meet the threshold. The distinction lies in duration, severity, and how much it disrupts your life. Left untreated, a depressive episode typically lasts 6 to 12 months.
What Causes It
Unipolar depression doesn’t have a single cause. It emerges from a combination of genetic vulnerability and life circumstances, and the balance between those two factors varies from person to person.
The genetic component is significant. Heritability estimates for unipolar depression range from 40% to 70%, meaning your genes account for a substantial portion of your risk. One well-studied genetic variation involves a gene that controls how your brain recycles serotonin. People carrying certain versions of this gene are up to twice as likely to develop depression after stressful life events like losing a job, a serious illness, or the end of a relationship.
Early life experiences play a powerful role as well, and they interact directly with genetic risk. Adults who experienced four or more types of severe childhood trauma face a more than fourfold increase in depressive symptoms and roughly a twelvefold increase in attempted suicide. Childhood maltreatment appears to be especially damaging for people who already carry genetic variants linked to depression, creating a compounding effect that can shape emotional responses for decades.
What’s Happening in the Brain
At a biological level, depression involves disruptions in three key chemical messenger systems: serotonin, norepinephrine, and dopamine. These chemicals regulate mood, motivation, energy, and emotional responses. In people with depression, the production, release, or recycling of these messengers can be impaired across multiple brain regions.
Serotonin has received the most attention. Low serotonin activity in the brain is linked to intensified negative emotions, including persistent sadness, self-criticism, irritability, anxiety, and feelings of isolation. Norepinephrine and serotonin also interact with each other directly. Norepinephrine helps regulate serotonin release, so disruptions in one system can cascade into the other. Dopamine, which drives motivation and the ability to feel pleasure, helps explain why depression so often strips away enjoyment from things that once felt rewarding.
Physical Health Effects
Depression is not purely a mood disorder. More than a third of the nonfatal health burden in people with major depression comes from co-occurring physical conditions, including cardiovascular disease, respiratory conditions like asthma, chronic pain, and gastrointestinal problems. People with heart disease, cancer, and neurodegenerative conditions also develop depression at substantially higher rates than the general population. The relationship runs in both directions: depression worsens physical illness, and physical illness increases the likelihood of depression.
How It’s Treated
Treatment for unipolar depression typically involves medication, psychotherapy, or a combination of both. The most commonly prescribed medications are SSRIs, which work by increasing serotonin availability in the brain. These are considered first-line treatment. A second class of medications, SNRIs, targets both serotonin and norepinephrine and is often used when SSRIs alone aren’t enough.
Most people notice improvement within a few weeks of starting medication, though it can take longer to find the right one. Not everyone responds to the first medication they try.
Two forms of therapy have the strongest evidence for depression. Cognitive behavioral therapy (CBT) focuses on identifying and changing negative thought patterns that feed depressive cycles. Interpersonal therapy (IPT) focuses on improving relationships and communication patterns that may be contributing to or worsening depression. In head-to-head comparisons, both produce meaningful improvement. One study found that 76% of CBT participants and 79% of IPT participants reached recovery thresholds on a standard depression scale, suggesting both are effective with a slight edge for IPT in some measures.
Combining medication with therapy tends to produce better outcomes than either approach alone, particularly for moderate to severe episodes.
When Standard Treatment Doesn’t Work
Depression is considered treatment-resistant when it doesn’t respond satisfactorily to at least two adequate trials of antidepressant medication. At that point, options expand to include transcranial magnetic stimulation (TMS), a noninvasive procedure that uses magnetic pulses to stimulate specific brain areas involved in mood regulation. Newer treatments like nasal spray formulations targeting different brain pathways have also been approved for treatment-resistant cases. Switching between medication classes, adding psychotherapy if it wasn’t already part of the plan, or combining approaches in new ways are all standard next steps.
Long-Term Outlook and Recurrence
One of the most important things to understand about unipolar depression is its tendency to come back. Roughly 85% of people who recover from a first depressive episode will experience another one within 15 years, and each additional episode increases the risk of future relapse by about 18%. Among people who respond well to therapy, about 29% relapse within the first year after treatment ends, and that number climbs to 54% within two years without ongoing maintenance treatment.
These numbers aren’t meant to discourage. They highlight why long-term strategies matter. Continuation treatment, whether that means staying on medication, returning for periodic therapy sessions, or both, significantly reduces the chance of relapse. Depression is best understood not as a single event to get through but as a recurring condition that benefits from sustained management, much like high blood pressure or diabetes. The earlier treatment begins and the more consistently it’s maintained, the better the long-term trajectory.